Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about NASDAQ:IMUX Recent news which mentions NASDAQ:IMUX Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day May 30, 2024 Tags NASDAQ:IMUX From News Direct Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day May 20, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic chief medical officer discusses promising treatments to mark World IBD Day May 17, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day May 16, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones May 09, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct IMUX Stock Earnings: Immunic Misses EPS for Q1 2024 May 08, 2024 Tickers IMUX Tags NASDAQ:IMUX Earnings Reports IMUX From InvestorPlace Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal May 01, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role April 29, 2024 Tags NASDAQ:IMUX From News Direct Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month March 21, 2024 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic secures key patent, boosting MS drug exclusivity and global IP strategy March 21, 2024 Tags NASDAQ:IMUX From News Direct Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024 March 08, 2024 Tags NASDAQ:IMUX From News Direct Immunic reports successful 2023 and prepares for key 2025 milestones February 22, 2024 Tags NASDAQ:IMUX From News Direct Immunic focusing on business development during Q4 November 14, 2023 Tags NASDAQ:IMUX From News Direct Immunic CSO hails "great" progress with MS program October 24, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic "super excited" about latest PMS trial data October 11, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment August 21, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic CEO says Q2 results "couldn't be better" August 07, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic Inc eyeing "big step" for multiple sclerosis patients July 25, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases June 26, 2023 Tags NASDAQ:IMUX From News Direct Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis May 31, 2023 Tags NASDAQ:IMUX From News Direct Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program May 17, 2023 Tags NASDAQ:IMUX From News Direct Immunic Inc set to bring relief with encouraging results May 16, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic IMU-856 trial data "clearly goes beyond" initial expectations May 04, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct Immunic gets a "positive surprise" from lead asset trial April 13, 2023 Tickers IMUX Tags NASDAQ:IMUX From News Direct 2 Biotech Stocks to Take off Your Watchlist in 2022 October 19, 2022 Tags NASDAQ:IMUX :DNA From StockNews.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.